In recent years, Variant Infectious Bursal Disease (Variant IBD) has emerged as one of the most formidable challenges in the poultry industry.

The danger lies not in high mortality rates—as seen with classical strains—but in the complete destruction of the flock’s immune system, even in the presence of classical maternal antibodies (MDA).

Why is Variant Gumboro considered more dangerous than the classical strain?

This is because modern variant strains possess a high capability for:

• Inducing Early Immunosuppression: Bypassing early immune defenses.
• Destroying B-cells: Targeting the bursa of Fabricius, which leads to severe flock complications, including:

o Unexplained CRD Outbreaks: Chronic Respiratory Disease cases that do not respond to standard protocols.
o Severely Depressed Vaccine Response: Poor titers and failure of subsequent vaccinations.
o Increased Secondary Infections: Higher susceptibility to opportunistic pathogens.
o Prolonged Disease Duration: Extended recovery periods and chronic morbidity.
o Poor Feed Conversion Ratios (FCR): Significant loss in growth performance and lack of response to medicinal treatments.

Recommendations

• Rigorous Laboratory Monitoring: Consistent oversight of flock health status.
• Diagnostic Testing: Conducting specialized serological and molecular assays for the flock.
• Strategic Vaccination: Selecting the appropriate vaccine strain that specifically matches the field challenge.